Stay up to date on NKMax America’s company news and announcements.

Press Releases

NKMax and Merck KGaA, Darmstadt, Germany Expand Clinical Collaboration to Include Phase I/IIa Trial Investigating the Combination of SNK01 with ERBITUX® (cetuximab) in Metastatic NSCLC

Affimed and NKMax America Announce FDA Clearance of IND Application to Study the Combination of AFM24, an EGFR Targeted Innate Cell Engager, with SNK-01 Natural Killer Cell Therapy in Solid Tumors

Subscribe to NKMax News Updates

* indicates required

NKMax Events

Check back soon for upcoming events!

NKMax on Social Media

Follow NKMax on social media to keep up-to-date on the latest company news and the science of Natural Killer cells!